Close Menu

NEW YORK — CytoDyn said on Monday that it has signed a nonbinding agreement to license its humanized antibody-based cancer and HIV drug leronlimab to IncellDx for diagnostic applications.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.